Literature DB >> 22566596

Impact commentaries. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Philip Scheltens1, Laura van de Pol.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22566596     DOI： 10.1136/jnnp-2012-302562

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  19 in total

1.  The relationship of weight change trajectory with medial temporal lobe atrophy in patients with mild Alzheimer's disease: results from a cohort study.

Authors:  Erika Droogsma; Dieneke van Asselt; Hanneli Bieze; Nic Veeger; Peter Paul De Deyn
Journal:  Alzheimers Res Ther       Date:  2015-04-06       Impact factor: 6.982

2.  Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients.

Authors:  Gustav Torisson; Danielle van Westen; Lars Stavenow; Lennart Minthon; Elisabet Londos
Journal:  BMC Geriatr       Date:  2015-06-16       Impact factor: 3.921

3.  A comparison of measurement methods of hippocampal atrophy rate for predicting Alzheimer's dementia in the Aberdeen Birth Cohort of 1936.

Authors:  Arnab K Rana; Anca-Larisa Sandu; Kenna L Robertson; Christopher J McNeil; Lawrence J Whalley; Roger T Staff; Alison D Murray
Journal:  Alzheimers Dement (Amst)       Date:  2016-12-23

4.  Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.

Authors:  Jules J Claus; Salka S Staekenborg; Dana C Holl; Jelmen J Roorda; Jacqueline Schuur; Pieter Koster; Caroline E M Tielkes; Philip Scheltens
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

5.  Early Detection of Alzheimer's Disease Using Non-invasive Near-Infrared Spectroscopy.

Authors:  Rihui Li; Guoxing Rui; Wei Chen; Sheng Li; Paul E Schulz; Yingchun Zhang
Journal:  Front Aging Neurosci       Date:  2018-11-09       Impact factor: 5.750

6.  Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease.

Authors:  Klaus Hager; Alan S Baseman; Jeffrey S Nye; H Robert Brashear; John Han; Mary Sano; Bonnie Davis; Henry M Richards
Journal:  Neuropsychiatr Dis Treat       Date:  2014-02-21       Impact factor: 2.570

7.  The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer's disease patients: study protocol for a randomized controlled trial.

Authors:  Weina Peng; Jing Zhou; Min Xu; Qing Feng; Lulu Bin; Zhishun Liu
Journal:  Trials       Date:  2017-07-03       Impact factor: 2.279

8.  Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment.

Authors:  Jung-Min Pyun; Young Ho Park; Hang-Rai Kim; Jeewon Suh; Min Ju Kang; Beom Joon Kim; Young Chul Youn; Jae-Won Jang; SangYun Kim
Journal:  Alzheimers Res Ther       Date:  2017-12-16       Impact factor: 6.982

9.  The Study of White Matter Hyperintensity (WMH) and Factors Related to Geriatric Late-Onset Depression.

Authors:  Jinghua Wang; Wei Li; Ling Yue; Bo Hong; Na An; Guanjun Li; Shifu Xiao
Journal:  Shanghai Arch Psychiatry       Date:  2018-02-25

10.  Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodology.

Authors:  Yiqi Lin; Binyin Li; Huidong Tang; Qun Xu; Yuncheng Wu; Qi Cheng; Chunbo Li; Shifu Xiao; Lu Shen; Weiguo Tang; Hui Yu; Naying He; Huawei Lin; Fuhua Yan; Wenwei Cao; Shilin Yang; Ye Liu; Wei Zhao; Dong Lu; Bin Jiao; Xuewen Xiao; Lin Zhou; Shengdi Chen
Journal:  BMC Neurol       Date:  2018-07-24       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.